Literature DB >> 12727623

Coordination of T cell activation and migration through formation of the immunological synapse.

Michael L Dustin1.   

Abstract

T cell activation is based on interactions of T cell antigen receptors with MHC-peptide complexes in a specialized cell-cell junction between the T cell and antigen-presenting cell-the immunological synapse. The immunological synapse coordinates naïve T cell activation and migration by stopping T cell migration with antigen-presenting cells bearing appropriate major histocompatibility complex (MHC) peptide complexes. At the same time, the immunological synapse allows full T cell activation through sustained signaling over a period of several hours. The immunological synapse supports activation in the absence of continued T cell migration, which is required for T cell activation through serial encounters. Src and Syk family kinases are activated early in immunological synapse formation, but this signaling process returns to the basal level after 30 min; at the same time, the interactions between T cell receptors (TCRs) and MHC peptides are stabilized within the immunological synapse. The molecular pattern of the mature synapse in helper T cells is a self-stabilized structure that is correlated with cytokine production and proliferation. I propose that this molecular pattern and its specific biochemical constituents are necessary to amplify signals from the partially desensitized TCR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727623     DOI: 10.1111/j.1749-6632.2003.tb06032.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

1.  2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1.

Authors:  Roberto Carreño; Wells S Brown; Dan Li; Jessica A Hernandez; Yang Wang; Tae Kon Kim; John W Craft; Krishna V Komanduri; Laszlo G Radvanyi; Patrick Hwu; Jeffrey J Molldrem; Glen B Legge; Bradley W McIntyre; Qing Ma
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

2.  Specific patterns of Cdc42 activity are related to distinct elements of T cell polarization.

Authors:  Irina Tskvitaria-Fuller; Abhinav Seth; Neeta Mistry; Hua Gu; Michael K Rosen; Christoph Wülfing
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

3.  Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors.

Authors:  Gabriella Henel; Karnail Singh; Dapeng Cui; Sergey Pryshchep; Won-Woo Lee; Cornelia M Weyand; Jörg J Goronzy
Journal:  Blood       Date:  2006-02-09       Impact factor: 22.113

4.  LFA-1 affinity regulation is necessary for the activation and proliferation of naive T cells.

Authors:  Yang Wang; Dan Li; Roza Nurieva; Justin Yang; Mehmet Sen; Roberto Carreño; Sijie Lu; Bradley W McIntyre; Jeffrey J Molldrem; Glen B Legge; Qing Ma
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

Review 5.  Traditional Chinese medicine and immune regulation.

Authors:  Hong-Di Ma; Yan-Ru Deng; Zhigang Tian; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

Review 6.  How the immune system talks to itself: the varied role of synapses.

Authors:  Jianming Xie; Cristina M Tato; Mark M Davis
Journal:  Immunol Rev       Date:  2013-01       Impact factor: 12.988

7.  Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs.

Authors:  Dan Li; Yufeng Li; Jessica A Hernandez; Rebecca Patenia; Tae Kon Kim; Jahan Khalili; Mark C Dougherty; Patrick J Hanley; Catherine M Bollard; Krishna V Komanduri; Patrick Hwu; Richard E Champlin; Laszlo G Radvanyi; Jeffrey J Molldrem; Qing Ma
Journal:  J Immunother       Date:  2010 Nov-Dec       Impact factor: 4.456

8.  Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance.

Authors:  Zhiya Yu; Marc R Theoret; Christopher E Touloukian; Deborah R Surman; Scott C Garman; Lionel Feigenbaum; Tiffany K Baxter; Brian M Baker; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

9.  Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.

Authors:  Yang Wang; Dan Li; Dan Jones; Roland Bassett; George E Sale; Jahan Khalili; Krishna V Komanduri; Daniel R Couriel; Richard E Champlin; Jeffrey J Molldrem; Qing Ma
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-07       Impact factor: 5.742

10.  LFA-1 regulates CD8+ T cell activation via T cell receptor-mediated and LFA-1-mediated Erk1/2 signal pathways.

Authors:  Dan Li; Jeffrey J Molldrem; Qing Ma
Journal:  J Biol Chem       Date:  2009-05-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.